Elie Bechara, Clinical Instructor of Pediatrics at AUBMC, shared a post on LinkedIn:
“Happy to share our latest article. We have demonstrated the successful implementation of a risk-adapted, response-based strategy for the treatment of pediatric patients with Hodgkin Lymphoma using the Euronet-PHL-C1 protocol; which yielded excellent overall survival of 97.6%, and allowed the omission of Radiotherapy in low stage patients who achieved early response to induction therapy.”
Title: Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet‐PHL‐C1 Protocol: Experience From a Resource‐Limited Country
Authors: Elie Bechara, Toufic Eid, Arwa El-Dhuwaib, Hani Tamim, Dolly Noun, Raphah Borghol, Zaher Chakhachiro, Miguel R Abboud, Samar Muwakkit
More posts featuring Hodgkin Lymphoma on OncoDaily.